Herpesvirus saimiri has characteristics that make it amenable to developmen
t as a gene therapy vector. The viral genome is thought to be capable of ac
commodating large quantities of heterologous DNA while the virus itself can
infect many different cell types. Virus infection has been shown in many c
ases to be persistent by virtue of episomal maintenance in the target cell.
In this article we examine the ability of nonselectable recombinant viruse
s expressing the beta-galactosidase gene product to infect a variety of hum
an cells and demonstrate that this virus could be developed as an alternati
ve hematopoietic stem cell gene therapy vector. In contrast to earlier obse
rvations, we demonstrate by a number of methods that the virus has the abil
ity to replicate in many human cell types, suggesting the need for the deve
lopment of a disabled virus for use as a gene therapy vector. J. Med. Virol
. 57:269-277, 1999. (C) 1999 Wiley-Liss, Inc.